jRCT1031250721招募中不适用
A Multicenter Retrospective Cohort Study Evaluating the Efficacy and Safety of Datopotamab Deruxtecan for Patients with Hormone Receptor-positive HER2 Negative Inoperable or Recurrent Breast Cancer in Japan (DAHLIA study) (JBCRG-C14(DAHLIA study))
未提供0 个研究点目标入组 300 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients with unresectable or recurrent breast cancer
- •Patients diagnosed with pathologically hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer
- •Patients who initiated Dato-DXd treatment for the first time between March 19, 2025, and December 31, 2025
- •Patients aged 18 years or older at the time of Dato-DXd initiation
- •Patients who provided written informed consent to participate in this study*
- •For patients for whom obtaining consent is difficult, opt-out enrollment is permitted after providing an adequate opportunity to decline.
排除标准
- •Patients who received Dato-DXd outside of insurance-covered treatment
- •Patients deemed ineligible for study enrollment by the attending physician
研究者
相似试验
尚未招募
不适用
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi MaintenancePrimary Peritoneal CarcinomaOvarian CancerNCT07269574Tongji Hospital600
尚未招募
不适用
A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple MastectomyBreast CancerNCT07257003Du Zhenggui150
尚未招募
不适用
Circumferential Pulmonary Venous Isolation Combined With Bachmann Bundle Modification Versus Circumferential Pulmonary Venous Isolation for Persistent Atrial FibrillationPersistent Atrial FibrillationNCT07445360Shenyang Northern Hospital320
尚未招募
不适用
Real-time Feedback of Red-out Within Colonoscopy IntubationNCT07273890The First Affiliated Hospital of Anhui Medical University576
尚未招募
不适用
CGUARDIANS III IDE Pivotal TrialCarotid Artery StenosisNCT07277296InspireMD103